NEVIRAPINE
Generic: NEVIRAPINE
Camber PharmaceuticalsManufacturer
ORALRoute
NEVIRAPINEActive Substance
2012-05-22Original Approval
NEVIRAPINE is FDA application ANDA078584, sponsored by HETERO LABS LTD III. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
FOETAL EXPOSURE DURING PREGNANCY
1,130 reports
2
DRUG RESISTANCE
1,033 reports
3
VIROLOGIC FAILURE
800 reports
4
VIRAL MUTATION IDENTIFIED
696 reports
5
DEATH
501 reports
6
EXPOSURE DURING PREGNANCY
465 reports
7
HIV INFECTION
432 reports
8
DRUG INEFFECTIVE
406 reports
9
PATHOGEN RESISTANCE
387 reports
10
TREATMENT FAILURE
336 reports